Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Fulgent Genetics United States | 49 | 15 |
|
Neuro-Ophthalmic Disorders NGS Panel Fulgent Genetics United States | 52 | 26 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Fulgent Genetics United States | 505 | 132 |
|
Gillespie Syndrome (PAX6 Single Gene Test) Fulgent Genetics United States | 8 | 1 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Fulgent Genetics United States | 13 | 3 |
|
Fulgent Genetics United States | 533 | 149 |
|
Microphthalmia, Anophthalmia, and Coloboma Panel NGS Panel Fulgent Genetics United States | 244 | 78 |
|
Ataxia, Complete Dominant Evaluation Athena Diagnostics United States | 31 | 25 |
|
Ataxia, Supplemental Dominant Evaluation Athena Diagnostics United States | 22 | 16 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics United States | 44 | 42 |
|
Molecular Vision Laboratory United States | 12 | 4 |
|
Invitae United States | 46 | 32 |
|
Ataxia, autosomal dominant and X-linked Panel CeGaT GmbH Germany | 12 | 34 |
|
MVZ Dr. Eberhard & Partner Dortmund Germany | 8 | 1 |
|
CeGaT GmbH Germany | 8 | 1 |
|
Ataxia and differential diagnoses Panel CeGaT GmbH Germany | 173 | 204 |
|
Developmental Eye Disease panel Molecular Vision Laboratory United States | 107 | 59 |
|
Fulgent Genetics United States | 8 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.